MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation

被引:26
作者
Zhang, Ting [1 ,2 ]
Zhang, Yanan [1 ,3 ]
Liu, Jie [1 ]
Ma, Yan [1 ,4 ]
Ye, Qinong [1 ]
Yan, Xinlong [2 ]
Ding, Lihua [1 ]
机构
[1] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China
[2] Beijing Univ Technol, Fac Environm & Life, Beijing, Peoples R China
[3] Beijing Inst Basic Med Sci, Brain Sci Ctr, Beijing, Peoples R China
[4] 970 Hosp Joint Logist Support Force PLA, Yantai, Peoples R China
基金
中国博士后科学基金;
关键词
Hepatocellular carcinoma; miR-377-3p; CPT1C; Fatty acid oxidation; Tumor growth; Metastasis; CARNITINE PALMITOYLTRANSFERASE 1C; TUMOR-GROWTH; CELL PROLIFERATION; CANCER; METABOLISM; CPT1C;
D O I
10.1186/s40170-021-00276-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Altered lipid metabolism is closely related to the occurrence and development of hepatocellular carcinoma (HCC). Carnitine palmitoyltransferase 1C (CPT1C) is a member of CPT1 family and plays a key role in cancer development and progression. However, how microRNAs (miRNAs) regulate CPT1C-mediated fatty acid transport and oxidation remains to be elucidated. Methods Oil Red O staining, mitochondrial, and lipid droplets immunofluorescence staining were used to detect the functions of miR-377-3p and CPT1C in fatty acid oxidation. Colocalization of palmitate and mitochondria was performed to investigate the function of miR-377-3p and CPT1C in fatty acid transport into mitochondria. Fatty acid oxidation (FAO) assay was used to detect the function of miR-377-3p and CPT1C in FAO. Cell proliferation, migration and invasion assays and animal experiments were used to evaluate the role of miR-377-3p/CPT1C axis in HCC progression in vitro and in vivo. Immunofluorescence staining was used to identify the clinical significance of miR-377-3p and CPT1C in HCC patients. Results MiR-377-3p inhibits CPT1C expression by targeting its 3'-untranslated region. Through repression of CPT1C, miR-377-3p suppresses fatty acid oxidation by preventing fatty acid from entering into mitochondria and decreasing ATP production in HCC cells. Inhibiting fatty acid oxidation abolishes the ability of miR-377-3p/CPT1C axis to regulate HCC proliferation, migration, invasion and metastasis in vitro and in vivo. In HCC patients, CPT1C is significantly upregulated, and miR-377-3p expression and lipid droplets are negatively correlated with CPT1C expression. High expression of miR-377-3p and CPT1C predict better and worse clinical outcomes, respectively. Conclusions We uncover the key function and the relevant mechanisms of the miR-377-3p/CPT1C axis in HCC, which might provide a potential target for the treatment of HCC.
引用
收藏
页数:16
相关论文
共 44 条
  • [31] Cancer statistics, 2019
    Siegel, Rebecca L.
    Miller, Kimberly D.
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (01) : 7 - 34
  • [32] CPT1c is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity
    Sierra, Adriana Y.
    Gratacos, Esther
    Carrasco, Patricia
    Clotet, Josep
    Urena, Jesus
    Serra, Dolors
    Asins, Guillermina
    Hegardt, Fausto G.
    Casals, Nuria
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (11) : 6878 - 6885
  • [33] Hepatocellular carcinoma in the era of immunotherapy
    Sim, Hao-Wen
    Knox, Jennifer
    [J]. CURRENT PROBLEMS IN CANCER, 2018, 42 (01) : 40 - 48
  • [34] Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
    Snaebjornsson, Marteinn Thor
    Janaki-Raman, Sudha
    Schulze, Almut
    [J]. CELL METABOLISM, 2020, 31 (01) : 62 - 76
  • [35] Effect of exosomal miRNA on cancer biology and clinical applications
    Sun, Zhenqiang
    Shi, Ke
    Yang, Shuaixi
    Liu, Jinbo
    Zhou, Quanbo
    Wang, Guixian
    Song, Junmin
    Li, Zhen
    Zhang, Zhiyong
    Yuan, Weitang
    [J]. MOLECULAR CANCER, 2018, 17
  • [36] Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas
    Wakamiya, Tomihiro
    Suzuki, Satoshi O.
    Hamasaki, Hideomi
    Honda, Hiroyuki
    Mizoguchi, Masahiro
    Yoshimoto, Koji
    Iwaki, Toru
    [J]. NEUROPATHOLOGY, 2014, 34 (05) : 465 - 474
  • [37] Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria- associated metabolic reprograming
    Wang, Yongtao
    Chen, Yixin
    Guan, Lihuan
    Zhang, Huizheng
    Huang, Yaoyao
    Johnson, Caroline H.
    Wu, Zeming
    Gonzalez, Frank J.
    Yu, Aiming
    Huang, Peng
    Wang, Ying
    Yang, Shouhui
    Chen, Pan
    Fan, Xiaomei
    Huang, Min
    Bi, Huichang
    [J]. CELL DEATH AND DIFFERENTIATION, 2018, 25 (04) : 733 - 746
  • [38] Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
    White, Donna L.
    Kanwal, Fasiha
    El-Serag, Hashem B.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (12) : 1342 - +
  • [39] Control of energy homeostasis: Role of enzymes and intermediates of fatty acid metabolism in the central nervous system
    Wolfgang, Michael J.
    Lane, M. Daniel
    [J]. ANNUAL REVIEW OF NUTRITION, 2006, 26 : 23 - 44
  • [40] The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis
    Wolfgang, Michael J.
    Kurama, Takeshi
    Dai, Yun
    Suwa, Akira
    Asaumi, Makoto
    Matsumoto, Shun-ichiro
    Cha, Seung Hun
    Shimokawa, Teruhiko
    Lane, M. Daniel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (19) : 7282 - 7287